Transgenic mice with overexpression of activating transcription factor 3 (ATF3) have been shown to develop cardiac remodeling, including LV hypertrophy and systolic dysfunction, and showed enhanced tumor growth in orthotopic breast cancer and xenograft lung cancer models [24]. The gene discussed is ATF3; the disease is breast carcinoma.